Revatio Articles
Internet "Vital And Positive Source" For Pharma Info
19 October 1998
US Majors Post Strong Earnings For 3rd Quarter
15 October 1998
Viagra Now Available "At Low Price" In Italy
14 October 1998
Hong Kong Estimates Size Of Viagra Bill
13 October 1998
Stock Commentary New York
8 October 1998
Viagra In Belgium
8 October 1998
Lilly Licenses ICOS' Viagra Clone
6 October 1998
Viagra In France
1 October 1998
ED: Better Communication & Education Still Needed
24 September 1998
Stock Commentary
24 September 1998
ICOS's LeukArrest Disappoints In MS
21 September 1998
World Pharma Market To Hit $308 Bill For 1998
18 September 1998
India To Source Bulk Viagra Locally
17 September 1998
Pfizer Begins EU Roll-Out Of Viagra After Approval
17 September 1998
Vietnam: Arrests In Fake Drug Seizures
16 September 1998
Angry Response To Interim Ban On Viagra In UK
16 September 1998
Pfizer Says Viagra Bill For UK Exaggerated
11 September 1998
Pfizer Stock Drops As Analyst Cuts Rating
8 September 1998
Pakistani Medicines To Nigeria?
7 September 1998
Rx Drug Sales Up 6% In 12 Months To April 1998
4 September 1998
EU Approval of Viagra Due In September
26 August 1998
Review Of US Second Qtr & Implications For Euro Firms
20 August 1998
Japan To Accept Foreign Clinical Test Data For NDAs
18 August 1998
Brazilian Fake Drugs Boost Hologram Sales
10 August 1998
Viagra To Be Launched In Russia In October
6 August 1998
German "No" To Viagra Reimbursement
5 August 1998
Jordan Concern Over Drug Promotion
30 July 1998
Indian Competition To Viagra
29 July 1998
Pfizer Appointments
23 July 1998
Chilean Firms Growing, R&D Spending Stays Low
22 July 1998
Vivus Sales Down
21 July 1998
Stock Commentary New York
16 July 1998
Viagra Approved In Israel
16 July 1998
First Approval For Senetek's Invicorp
14 July 1998
"Extraordinary"Viagra Sales Lift Pfizer Earnings
10 July 1998
Copromotion For MUSE In USA
9 July 1998
Vivus Stock Rising To Impotence Challenge
9 July 1998
Viagra Sales To Reach $1 Billion In First Year
9 July 1998
Stock Commentary New York
9 July 1998
Japanese Journal Faces Probe Over Viagra
3 July 1998
Stock Commentary New York
2 July 1998
100 serious reactions to Viagra
2 July 1998
UK Crackdown On Illegal Sales Of Viagra
1 July 1998
Bright Future For Biotech Sector, BIO '98
26 June 1998
Switzerland Latest Market For Viagra
25 June 1998
Leading HMO To Exclude Viagra
24 June 1998
FDA Says Pfizer's Zeldox Is "Non-Approvable"
24 June 1998
Hungary Outlaws Viagra Sales/Ads
23 June 1998
Euro CPMP April Plenary Meeting
18 June 1998
New Jersey Sets Limits On Viagra Cover
15 June 1998
Viagra Still Riding High, But Competition Looms
15 June 1998
Boom For UK's BTP
15 June 1998
Israel Ends Prescribing Ban On Viagra
15 June 1998
WHO Slams Internet Drug Sales, Promo
15 June 1998
States To Pay Medicaid Purchases Of Viagra
15 June 1998
Stock Commentary New York
4 June 1998
Viagra "Will Be Rx Only" In Malaysia
4 June 1998
Pfizer's Viagra Backed By CPMP
4 June 1998
UK Drug Use Decisions "Need Public Input"
2 June 1998
Spain Views Viagra Reimbursement
2 June 1998
Stock Commentary New York
28 May 1998
Germany Views Impotence Drugs, Doctors' Budgets
26 May 1998
New York Stock Comment
21 May 1998
USA's Most-Dispensed Rx Drugs In April 1998
20 May 1998
Black Market Sales Of Viagra In Saudi Arabia
19 May 1998
Stock Commentary New York
14 May 1998
Unapproved Drugs Imported Into Japan
8 May 1998
Stock Commentary New York
7 May 1998
Pfizer Looks At Viagra In Women
30 April 1998
Pfizer's Viagra Already Has 95% Share Of ED Market
30 April 1998
Stock Commentary New York
23 April 1998
Pfizer Gets Restraining Order In Viagra Lawsuit
23 April 1998
PowderJect's Needlefree Alprostadil
22 April 1998
Unprecedented Take-Off For Pfizer's Viagra
21 April 1998
Pfizer Posts Double-Digit Sales & Earnings Growth
15 April 1998
Demand For Vivus' MUSE Remains Flat
15 April 1998
Analysts Forecast Bright Outlook For US Majors
8 April 1998
Vivus To Triple Its Sales Force
1 April 1998
Pfizer's Impotence Pill Wins FDA Clearance
31 March 1998
Stock Commentary New York
26 March 1998
Stock Commentary New York
5 March 1998
Minor Setback With Droloxifene For Pfizer
29 January 1998
ICOS' Oral Impotence Drug Enters Ph II
15 January 1998
Analysts Assess Outlook For US Drug Majors
8 January 1998
New Products In 1998; A Look Ahead
6 January 1998
1st Non-US Approval For VIVUS' MUSE
4 December 1997
Stock Commentary New York
7 November 1997
Pfizer's Viagra To Be Given Expedited Review
23 October 1997
Pfizer's Healthy Growth Lifted By Alliance Products
16 October 1997
Fournier's Erecnos Boosted By Clinical Trial Results
8 October 1997
Viagra Now Filed In EU and USA
2 October 1997
Merck Files NDA For Oral Impotence Drug
10 September 1997
Pfizer Enters New Product Cycle With Strong Potential
7 August 1997
New York Stock Comment
3 March 1997
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
